Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotateAmir Sabet, Khaled Ezziddin, Ulrich-Frank Pape, et al.
Clinical Nuclear Medicine|May 21, 2024
225 Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177 Lu-PSMA-617 Radioligand Therapy : Pilot Experience From a Prospective RegistryFlorian Rosar, Caroline Burgard, Luna Vanessa Rohloff, et al.
Thrombosis and Haemostasis|November 8, 2008
Subclinical hyperthyroidism seems not to have a significant impact on systemic anticoagulation in patients with coumarin therapyJan Bucerius, Anna Naubereit, Alexius Y Joe, et al.
Journal of Medicinal Chemistry|April 7, 2021
Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617Sebastian Martin, Roswitha Tönnesmann, Ina Hierlmeier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2013
Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumoursAmir Sabet, Torjan Haslerud, Ulrich-Frank Pape, et al.
American Journal of Nuclear Medicine and Molecular Imaging|October 12, 2013
Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysisAmir Sabet, Feras Khalaf, Torjan Haslerud, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2016
Radiosynoviorthesis in hemophilic arthropathy: pathologic blood pool imaging on pre-therapeutic bone scintigraphy is not a predictor of treatment successAmir Sabet, Andreas Christian Strauss, Jan Schmolders, et al.
Pageof 16